Inhibrx: The Biotech Spinoff Poised For Big Gains [Forbes]
Inhibrx Biosciences, Inc. (INBX)
Company Research
Source: Forbes
As an investor, my greatest returns have usually come from areas most people ignore. I concentrate on companies that analysts hardly cover or those spun off from more established companies. I gained my edge from digging here. Having seen something unique before it became mainstream after thirty years in the game has become second nature. Real chances lurk in this area, where others are not searching; Inhibrx Biosciences is a prime illustration of such potential. Inhibrx is a biotech company that develops new treatments for cancer and rare diseases. They use advanced techniques to create special proteins that target specific diseases, using their own unique technology to make these treatments as effective as possible. Although not yet well-known in households, the business is about to become significant. Inhibrx is getting closer to a breakthrough with a bright pipeline of creative therapies aimed at cancer and uncommon ailments. Their lead medicine is nearing the end of clinical
Show less
Read more
Impact Snapshot
Event Time:
INBX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INBX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INBX alerts
High impacting Inhibrx Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
INBX
News
- Inhibrx gains after insider purchases from CEO [Seeking Alpha]Seeking Alpha
- Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]Yahoo! Finance
- Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate HighlightsPR Newswire
- ISCG: Soft Quality, Elevated Volatility, Sluggish Performance [Seeking Alpha]Seeking Alpha
- Inhibrx, Inc. (NASDAQ: INBX) is now covered by analysts at JMP Securities. They set a "market perform" rating on the stock.MarketBeat
INBX
Earnings
- 2/28/24 - Miss
INBX
Sec Filings
- 9/16/24 - Form 4
- 9/12/24 - Form 4
- 9/10/24 - Form 4
- INBX's page on the SEC website